Related Experiment Videos
Progressive systemic sclerosis and the lung
1Division of Pulmonary and Critical Care Medicine, Los Angeles, CA 90033, USA.
Current Opinion in Pulmonary Medicine
|May 17, 2000
Abstract:
Pulmonary manifestations of systemic sclerosis (scleroderma) are many. The mean survival in these patients is 78 +/- 17 months. Improved diagnostic techniques and better therapeutic options are essential to stem the tide of overwhelming mortality in patients with scleroderma lung disease.